Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
s linking based on radically recoded bacterial genomes and/or Multi-virus- resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. EFTA00631419 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business m
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
s linking based on radically recoded bacterial genomes and/or Multi-virus- resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
s linking based on radically recoded bacterial genomes and/or Multi-virus- resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to
Sponsored
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
s linking based on radically recoded bacterial genomes and/or Multi-virus- resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to
Sponsored
Mutual Connections (18)
Entities connected to both Amyris and Dan Mandell
Jeffrey Epstein
PERSON7 w/ Amyris·4 w/ Dan
Marc Rich
PERSON7 w/ Amyris·4 w/ Dan
JQ
Justin Quinn
PERSON4 w/ Amyris·4 w/ Dan
Robert Gates
PERSON4 w/ Amyris·4 w/ Dan
Justin Trudeau
PERSON4 w/ Amyris·4 w/ Dan
JC
James Clement
PERSON4 w/ Amyris·4 w/ Dan
KE
Kevin Esvelt
PERSON4 w/ Amyris·4 w/ Dan
Space Genetics
ORGANIZATION4 w/ Amyris·4 w/ Dan
PM
Prashant Mali
PERSON4 w/ Amyris·4 w/ Dan
BD
Bobby Dhadwar
PERSON4 w/ Amyris·4 w/ Dan
TW
Ting Wu
PERSON4 w/ Amyris·4 w/ Dan
RT
Rich Terry
PERSON4 w/ Amyris·4 w/ Dan
MM
Margo Monroe
PERSON4 w/ Amyris·4 w/ Dan
the American Bison
ORGANIZATION3 w/ Amyris·3 w/ Dan
ES
Eswar
PERSON3 w/ Amyris·3 w/ Dan
LY
Luhan Yang
PERSON3 w/ Amyris·3 w/ Dan
Eric Trump
PERSON3 w/ Amyris·2 w/ Dan
HE
Helicos
PERSON2 w/ Amyris·2 w/ Dan